Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
9.32
+0.21 (2.36%)
Aug 21, 2026, 3:23 PM EDT - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $998.8 million as of August 21, 2026. Its market cap has increased by 126.64% in one year.
Market Cap
998.80M
Enterprise Value
641.28M
1-Year Change
126.64%
Ranking
Category
Stock Price
$9.32
ChartMarket Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has increased from $754.10M to $998.80M, an increase of 32.45%. That is a compound annual growth rate of 3.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 998.80M | 127.31% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 1.02B |
| Lexicon Pharmaceuticals | 1.01B |
| Climb Bio | 1.00B |
| Candel Therapeutics | 1.00B |
| Geron | 986.20M |
| Ardelyx | 980.55M |
| Immix Biopharma | 961.49M |
| Annexon | 955.48M |